TransCode Therapeutics, Inc. (RNAZ)
NASDAQ: RNAZ · Real-Time Price · USD
8.45
-0.07 (-0.82%)
Apr 28, 2026, 4:00 PM EDT - Market closed
TransCode Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 8 | 6 | 2 | 4 | 8 | 32 | |
| Market Cap Growth | -12.99% | 166.92% | -43.27% | -51.10% | -73.50% | - | |
| Enterprise Value | -10 | 3 | 1 | -3 | -0 | 9 | |
| Last Close Price | 8.45 | 6.83 | 94.36 | 6091.00 | 497486.69 | 1877587.23 | |
| PB Ratio | 0.75 | 0.04 | -1.16 | 2.52 | 2.61 | 1.56 | |
| P/TBV Ratio | - | - | - | 2.52 | 2.61 | 1.56 | |
| Debt / Equity Ratio | - | - | -0.02 | 0.28 | - | - | |
| Net Debt / Equity Ratio | -0.12 | -0.12 | 2.86 | -1.41 | -1.54 | -1.02 | |
| Net Debt / EBITDA Ratio | 0.93 | 0.93 | 0.37 | 0.12 | 0.27 | 3.41 | |
| Net Debt / FCF Ratio | 0.91 | 0.91 | 0.43 | 0.13 | 0.31 | 3.77 | |
| Quick Ratio | 5.37 | 5.37 | 2.10 | 0.79 | 1.15 | 8.22 | |
| Current Ratio | 6.29 | 6.29 | 2.56 | 1.28 | 1.70 | 8.97 | |
| Return on Equity (ROE) | -46.26% | -46.26% | - | -759.85% | -148.57% | -80.53% | |
| Return on Assets (ROA) | -14.14% | -14.14% | -157.06% | -190.26% | -76.30% | -32.05% | |
| Return on Capital Employed (ROCE) | -12.10% | -12.10% | -346.30% | -1156.50% | -575.00% | -30.10% | |
| Earnings Yield | -468.11% | -553.44% | -714.09% | -448.43% | -207.69% | -21.44% | |
| FCF Yield | -251.96% | -311.72% | -569.30% | -437.89% | -187.57% | -17.30% | |
| Buyback Yield / Dilution | -5392.22% | -5392.22% | - | - | - | - | |
Source: S&P Capital IQ. Standard template.
Financial Sources.